Global action against dementia

Program

Second Global Dementia Legacy Event
Co-hosted by Canada-France

Harnessing the Power of Discoveries:
Maximizing academia-industry synergies

September 11-12, 2014
Ottawa, Canada

Thursday – September 11, 2014

Legacy Event Opens

09:00-09:45

Opening addresses and official introductions

Alain Beaudet, President, Canadian Institutes of Health Research (CIHR) and Yves Lévy, Chairman and Chief Executive Officer, French National Institute of Health and Medical Research (Inserm) and Chairman of Aviesan (French national Alliance for life sciences and health care), welcome participants and dignitaries

Addresses by:

Rona Ambrose, Minister of Health, Canada
Philippe Zeller, Ambassador of France to Canada
Dennis Gillings, World Dementia Envoy
Matthew Dineen, dementia Caregiver
Faye Forbes, person living with dementia
Mimi Lowi-Young, Alzheimer Society of Canada
Inez Jabalpurwala, Brain Canada

All panel discussions are moderated by Michel Rochon, Science and Medical Journalist, Radio-Canada

10:05-11:05

Panel 1: Reflections on Innovative Academia - Industry Synergies

Introduction by Yves Joanette, CIHR Institute of Aging, Canada, and Etienne Hirsch, Aviesan, France

“Achieving Innovative Academia-Industry Synergies – A Real-life Example”
Brian Fiske, Michael J. Fox Foundation for Parkinson’s Research, USA

“Harnessing the Power of Collaboration to Cure the Ills of Life Science Innovation”
Chris Llewellyn, McKinsey Europe, UK

“Lessons from Academia-Industry Partnerships Around the World”
Dennis Gillings, World Dementia Envoy, UK

Discussion and exchange with participants
Discussants: Ms. Maria Carillo (USA)

11:05-12:15

Panel 2: Biotechnology and the Investment Community

“When Biotech Companies Take Advantage of Academia- Industry Synergies – A Real-life Example”
John Alam, EIP-Pharma, LLC, USA

“Massachusetts Biotech Cluster: CONNECT”
John Hallinan, Innovation Services Programs, MassBio, USA

“Conditions of Success for a Biotech Hub: A US/Europe Comparison”
Steven Casper, Keck Graduate Institute, USA

“How the Investment Community Can Contribute to Successful Academic-Industry Collaborations”
Andrea Ponti, GHO Capital Partners LLP, UK

Discussion and exchange with participants
Discussants: Mr. Pierluigi Nicotera (Germany), Mr. Simon Ridley (UK)

13:45-14:45

Panel 3: The Pharmaceutical Industry – Towards a New Paradigm

“The Health Care Industry: Towards Sustainable Innovation”
Luc Truyen, Johnson & Johnson Global Fight Against Alzheimer’s Disease, USA

“Novel Partnerships for New Science of Dementia”
Michel Goldman, Innovative Medicines Initiative, EU

“Faster Trials, Faster Medicines”
George Vradenburg, Global CEO Initiative, USA

Discussion and exchange with participants
Discussants: Mr. Richard Hodes (USA), Mr. Husseini Manji (USA), Mr. Ronald Petersen (USA)

15:05-16:20

Panel 4: New Opportunities from the Medical Device and Information Technology Industries

“The Role of Academia for SMEs in Developing Telemedicine Solutions for Dementia – A Real-Life Example”
Stephen Von Rump, Giraff Technologies AB, Sweden

“How Can the IT and Medical Device Industries Benefit from Enhanced Synergy with Academia?”
Thierry Zylberberg, Orange Healthcare, France

“OBI and HTX: Collaborative Medical Technology and Evidence Development to Meet Priority Health System Needs”
John Soloninka, HTX, Canada

“Fostering Innovation, Implementation and Scale-up of Health Information Technologies to Support Dementia Care in Health Systems”
Robyn Tamblyn, McGill University, Canada

Discussion and exchange with participants
Discussants: Mr. Geoff Fernie (Canada), Mr. Yoshiki Niimi (Japan), Ms. Diane Côté (Canada), Mr. François Berger (France)

16:20-16:30

Closing address by Yves Joanette, CIHR Institute of Aging, Canada, and Etienne Hirsch, Aviesan, France

Friday September 12, 2014

Legacy Event – Day 2

09:00-09:05

Opening addresses

Alain Beaudet, President, Canadian Institutes of Health Research (CIHR) and Yves Lévy, Chairman and Chief Executive Officer, French National Institute of Health and Medical Research (Inserm) and Chairman of Aviesan (French national Alliance for life sciences and health care)

09:05-10:15

Panel 5: Solutions to Regulatory Barriers: Regulatory Environment

“Regulatory Pathways for the Path to 2025”
Cynthia Duggan, New York Academy of Sciences, USA

“Current Status and Challenges of Japan for Promoting Anti-dementia Drugs Development”
Yoshiko Komuro, Pharmaceuticals and Medical Devices Agency, Japan

“Innovative Regulatory Pathways for Dementia: the Health Canada Perspective”
Robert Cushman, Health Canada, Canada

“World Dementia Council – Regulatory Update”
Raj Long, Bill & Melinda Gates Foundation, UK

Discussion and exchange with participants
Discussants: Mr. Howard Feldman (Canada), Mr. Nicholas Kozauer (USA)

10:15-11:20

Panel 6: Solutions to Barriers: Big Data, Open Access and Societal Considerations

“Status Report on the OECD Big Data and Sustainability Initiative for Large-scale Research on Dementia”
Robin Buckle, Medical Research Council, UK

“How Open Access Partnerships Between Industry and Academia Can Promote More Innovative Solutions for Dementia Research”
Aled Edwards, Structural Genomics Consortium, Canada

“Innovative Technology for People Living with Dementia: Current and Future Opportunities”
Mimi Lowi-Young, Alzheimer Society of Canada, Canada

Discussion and exchange with participants
Discussants: Mr. Philippe Amouyel (France), Mr. John Clarkson (Canada), Ms. Linda Elam (USA)

11:40-12:20

Implementing the Global Action Against Dementia

Addresses by:

Jon Rouse, Department of Health, UK
UK Legacy Event

Tadayuki Mizutani, Ministry of Health, Labour and Welfare, Japan
Japan Legacy Event

Richard Hodes, National Institute on Aging, USA
USA Legacy Event

Yves Joanette, CIHR Institute of Aging, Canada, and Etienne Hirsch, Aviesan, France
Key Messages from the Canada-France Legacy Event

Alain Beaudet, President, CIHR, Canada

Alice Wong, Minister of State (Seniors), Canada

Date modified: